Navigation Links
Ovarian cancer stem cell study puts targeted therapies within reach
Date:1/6/2013

Researchers at Yale School of Medicine have identified a key link between stem cell factors that fuel ovarian cancer's growth and patient prognosis. The study, which paves the way for developing novel targeted ovarian cancer therapies, is published online in the current issue of Cell Cycle.

Lead author Yingqun Huang, M.D., associate professor in the Department of Obstetrics, Gynecology & Reproductive Sciences, and her colleagues have demonstrated a connection between two concepts that are revolutionizing the way cancer is treated.

First, the "cancer stem cell" idea suggests that at the heart of every tumor there is a small subset of difficult-to-identify tumor cells that fuel the growth of the bulk of the tumor. This concept predicts that ordinary therapies typically kill the bulk of tumor cells while leaving a rich environment for continued growth of the stem cell tumor population.

The second concept, dubbed "seed and soil," defines a critical role for the tumor cells' "microenvironment," which is the special environment required for cancer cell growth and spread.

"Both concepts have particular relevance for the treatment of adult solid tumors such as ovarian cancer, which has been notoriously difficult to diagnose and treat," said co-author Nita J. Maihle, M.D., professor in the Department of Obstetrics, Gynecology & Reproductive Sciences and a member of Yale Cancer Center. "Ovarian cancer patients are plagued by recurrences of tumor cells that are resistant to chemotherapy, ultimately leading to uncontrolled cancer growth and death."

In this study, Huang and her colleagues were able to define a molecular basis for the interplay between these two concepts in ovarian cancer. They did this by using sophisticated gene sequencing methods to demonstrate a regulatory link between the stem cell factor Lin28 and the signaling molecule bone morphogenic protein 4 (BMP4).

"These results are supported by the
'/>"/>

Contact: Karen N. Peart
karen.peart@hotmail.com
203-432-1326
Yale University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Taller, Heavier Women May Face Higher Ovarian Cancer Risk
2. U.S. Panel Rejects Ovarian Cancer Screening
3. UC Irvine study finds racial, economic disparities in ovarian cancer care, survival
4. Internationally known expert in ovarian cancer to be honored at the ASCO Annual Meeting
5. The prevention of hereditary breast and ovarian cancer by PGD is feasible
6. Fertility preservation with cryopreservation of ovarian tissue: from experimental to mainstream
7. Ovarian Transplants May Preserve Fertility in Young Cancer Survivors
8. Benefit of PET and PET/CT in ovarian cancer is not proven
9. Mechanisms of acquired chemoresistance in ovarian cancer identified
10. U.S. Panel Rejects Ovarian Cancer Screens for Low-Risk Women
11. Simple ovarian cancer symptom survey that checks for 6 warning signs may improve early detection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... plays a central role in regulating appetite and whole-body ... the brain,s control of food intake and body weight, ... has been unclear. A new study in ... PPARγ activity in a type of neuron known as ... to high-fat diet. Sabrina Diano and colleagues at ...
(Date:8/1/2014)... 1, 2014 (HealthDay News) -- Almost 140 people ... transportation in the United States. But there ... catastrophes, Dawne Gardner, injury prevention coordinator at Cincinnati ... said in a medical center news release. ... to school, it,s important for parents and children ...
(Date:8/1/2014)... As AndroGel lawsuits and testosterone lawsuits ... Johnson, Jr. has been appointed as co-lead counsel to ... medications. Since the Fall of 2013, Ron and his ... to investigate and prosecute the claims of men who ... as a result of taking testosterone. As a result ...
(Date:8/1/2014)... August 01, 2014 Market Publishers ... reports have been added to its catalogue. ... Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services ... pharma industry drivers include, among others, increasing ageing ... hygiene. In 2015, the pharma market in India ...
(Date:8/1/2014)... HealthDay Reporter FRIDAY, Aug. ... as a time-honored destination for a good cut and conversation. ... also be the spot to tackle an often overlooked health ... novel partnership, the U.S. Centers for Disease Control and Prevention, ... the help of barbershop staff to both discuss and diagnose ...
Breaking Medicine News(10 mins):Health News:Expert Offers School Bus Safety Tips 2Health News:Ron Johnson Named Co-Lead Counsel in Lawsuits for Men Injured by AndroGel and Testosterone 2Health News:In-demand Markets Research Reports by Kelly Scientific Publications Now Available at MarketPublishers.com 2Health News:In-demand Markets Research Reports by Kelly Scientific Publications Now Available at MarketPublishers.com 3Health News:Barbershops Join Fight Against High Blood Pressure in Black Men 2Health News:Barbershops Join Fight Against High Blood Pressure in Black Men 3
... April 24 Choice Hotels,International (Choice) announced today ... insurance plan from Planned Administrators Inc.,(PAI), available to ... With the announcement, the franchisees that own ... in the United States now have the option ...
... 24 Boston Scientific,Corporation (NYSE: BSX ... the,Multicenter Automatic Defibrillator Implantation Trial with Cardiac,Resynchronization ... examines the potential benefits of Boston Scientific ... population of,heart failure patients. It is the ...
... Research Confirms Rounder Teeth Provide More Feminine and Youthful ... ... dentist Denise,Fundora, DDS ( http://www.fundoradental.com ) of Beverly Hills, CA states,"Changing the ... as rejuvenate your overall appearance. Some of my patients,say that a smile ...
... Their Computerized,Prescribing Systems Are Effective, First Use ... Survey, WASHINGTON, April 24 With the ... becomes the,first health care quality organization to add ... computerized medication prescribing systems are actually,catching common, serious ...
... of cancer, study warns , , THURSDAY, April 24 (HealthDay ... been successfully treated if ovarian or testicular tissue they ... back into their bodies without it being adequately checked ... , Researchers at two university hospitals in Israel, writing ...
... 24 Life Brokerage Partners,announces three additional carrier ... Polaris and United National Finance,Inc. ("UNF"). These premium ... they provide new methods for transacting,business., The ... and UNF,do not end with the agents, but ...
Cached Medicine News:Health News:Choice Hotels Selects PAI as Qualified Vendor to Offer Health Benefits to Part-Time, Hourly Workers in Its Franchisee Base 2Health News:Choice Hotels Selects PAI as Qualified Vendor to Offer Health Benefits to Part-Time, Hourly Workers in Its Franchisee Base 3Health News:Boston Scientific Completes Enrollment in Landmark Heart Failure Trial 2Health News:Boston Scientific Completes Enrollment in Landmark Heart Failure Trial 3Health News:'Size Does Matter ... and So Does Shape ... When It Comes to Teeth,' Says Cosmetic Dentist, Dr. Denise Fundora 2Health News:The Leapfrog Group Releases 2008 Hospital Survey Offering Consumers Greater Assurance of Safety 2Health News:The Leapfrog Group Releases 2008 Hospital Survey Offering Consumers Greater Assurance of Safety 3Health News:The Leapfrog Group Releases 2008 Hospital Survey Offering Consumers Greater Assurance of Safety 4Health News:Stored Ovarian Tissue Needs Testing Before Re-Implantation 2Health News:Life Brokerage Partners Strengthens Premium Finance Programs 2
(Date:8/1/2014)... 2014 Research and Markets ... Medical Biosensors Market 2014-2018" report to their ... Medical biosensors are used to analyze ... These biosensors monitor health status, disease betterment, and ... They are cost-effective and user-friendly devices. Also, they ...
(Date:8/1/2014)...  NxStage Medical, Inc. (Nasdaq: NXTM ), a ... Jeffrey H. Burbank , Chief Executive Officer, and Mathew ... th Annual Canaccord Genuity Growth Conference being held at ... Wednesday, August 13 th at 4:30 p.m. ET.  A ... http://ir.nxstage.com/ .  About NxStage Medical ...
(Date:8/1/2014)... , Aug. 1, 2014 Dyadic International, Inc. ... and proprietary technologies are used to develop, manufacture and ... chemical, biopharmaceutical and industrial enzyme industries, announced today that ... quarter ended June 30, 2014 after market close on ... call that day at 5:00 p.m. Eastern Time to ...
Breaking Medicine Technology:Global Medical Biosensors Market 2014-2018: Key Vendors are Abbott, Bayer, LifeScan and F. Hoffmann-La Roche 2NxStage to Present at the 34th Annual Canaccord Genuity Growth Conference 2Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 2Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 3